Close Menu

NEW YORK (GenomeWeb News) – PerkinElmer said after the close of the market on Friday that it entered into an agreement to provide it a $700 million committed unsecured revolving credit facility through Jan. 8, 2019.

JP Morgan Chase Bank acted as administrative agent on the facility, while Bank of America and Barclays Bank acted as co-syndication agents, PerkinElmer said in a document filed with the US Securities and Exchange Commission. The agreement was reached on Jan. 8 and replaces the second amended and restated and unsecured revolving credit agreement dated Dec. 16, 2011.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.